SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-000451
Filing Date
2024-02-12
Accepted
2024-02-12 07:05:32
Documents
16
Period of Report
2024-02-12

Document Format Files

Seq Description Document Type Size
1 6-K zk2430920.htm 6-K 15113
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 30860
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 22563
4 exhibit_99-2slide1.jpg GRAPHIC 101702
5 exhibit_99-2slide2.jpg GRAPHIC 382816
6 exhibit_99-2slide3.jpg GRAPHIC 144904
7 exhibit_99-2slide4.jpg GRAPHIC 166176
8 exhibit_99-2slide5.jpg GRAPHIC 109250
9 exhibit_99-2slide6.jpg GRAPHIC 94045
10 exhibit_99-2slide7.jpg GRAPHIC 124584
11 exhibit_99-2slide8.jpg GRAPHIC 135812
12 exhibit_99-2slide9.jpg GRAPHIC 127380
13 exhibit_99-2slide10.jpg GRAPHIC 123582
14 exhibit_99-2slide11.jpg GRAPHIC 109859
15 exhibit_99-2slide12.jpg GRAPHIC 157585
16 image00001.jpg GRAPHIC 3149
  Complete submission text file 0001178913-24-000451.txt   2523378
Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Filer) CIK: 0001593984 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36349 | Film No.: 24617345
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)